Kaylee Ermine

Tong J, Tan X, Hao S, Ermine K, Lu X, Liu Z, Jha A, Yu J, Zhang L. Inhibition of multiple CDKs potentiates colon cancer chemotherapy via p73-mediated DR5 induction. Oncogene. 2023 Mar;42(12):869-880. doi: 10.1038/s41388-023-02598-6. Epub 2023 Jan 31. PMID: 36721000

Kuang C, Tong J, Ermine K, Cai M, Dai F, Hao S, Giles F, Huang Y, Yu J, Zhang L. Dual inhibition of BET and HAT/p300 suppresses colorectal cancer via DR5- and p53/PUMA-mediated cell death. Front Oncol. 2022 Oct 12;12:1018775. doi: 10.3389/fonc.2022.1018775. eCollection 2022. PMID: 36313707

Tong J, Tan X, Song X, Gao M, Risnik D, Hao S, Ermine K, Wang P, Li H, Huang Y, Yu J, Zhang L. CDK4/6 Inhibition Suppresses p73 Phosphorylation and Activates DR5 to Potentiate Chemotherapy and Immune Checkpoint Blockade. Cancer Res. 2022 Apr 1;82(7):1340-1352. doi: 10.1158/0008-5472.CAN-21-3062. PMID: 35149588; PMCID: PMC8983601.

Tong J, Tan X, Risnik D, Gao M, Song X, Ermine K, Shen L, Wang S, Yu J, Zhang L. BET protein degradation triggers DR5-mediated immunogenic cell death to suppress colorectal cancer and potentiate immune checkpoint blockade. Oncogene. 2021 Dec;40(48):6566-6578. doi: 10.1038/s41388-021-02041-8. Epub 2021 Oct 6. PMID: 34615996; PMCID: PMC8642302.

Ermine K, Yu J, Zhang L. Role of Receptor Interacting Protein (RIP) kinases in cancer. Genes Dis. 2021 Nov 18;9(6):1579-1593. doi: 10.1016/j.gendis.2021.10.007. PMID: 36157481; PMCID: PMC9485196.